Involvement of adrenergic mechanism in the diuretic action of o-chlorobenzyl methyl sulfoxide (DS-30) in the rat.
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D006852:Hydrochlorothiazide / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008680:Metaraminol / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic; D013454:Sulfoxides / Q000494:pharmacology*; D014043:Tolazoline / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D001593:Benzyl Compounds; D004232:Diuretics; D011941:Receptors, Adrenergic; D013454:Sulfoxides; D006852:Hydrochlorothiazide; C005496:o-chlorobenzyl methyl sulfoxide; D005665:Furosemide; D008680:Metaraminol; D011433:Propranolol; D014043:Tolazoline; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine